LB Pharmaceuticals Inc. (LBRX)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
31. 41
+0.82
+2.6806%
$
900.73M Market Cap
- P/E Ratio
- Div Yield
147,900 Volume
- Eps
$ 30.59
Previous Close 
Want to track LBRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
All You Need to Know About LB Pharmaceuticals Inc (LBRX) Rating Upgrade to Buy
LB Pharmaceuticals Inc (LBRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks | 1 month ago
LB Pharmaceuticals Inc (LBRX) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
LB Pharmaceuticals Inc (LBRX) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
Seekingalpha | 3 months ago
LB Pharmaceuticals (NASDAQ:LBRX) Sets New 1-Year High – Here’s What Happened
LB Pharmaceuticals Inc (NASDAQ: LBRX - Get Free Report)'s stock price hit a new 52-week high during trading on Friday. The stock traded as high as $26.26 and last traded at $26.2950, with a volume of 47974 shares. The stock had previously closed at $24.94. Analyst Upgrades and Downgrades A number of equities analysts have
Defenseworld | 4 months ago
